(Bloomberg) -- A little known biotech company, ABVC BioPharma Inc., soared in U.S. premarket trading amid increasing chatter on trading social network StockTwits.
Most Read from Bloomberg
Into the Metaverse: Where Crypto, Gaming and Capitalism Collide
Can a New Mayor Fix Seattle’s Downtown?
The Terrifying Rise of Haunted Tourism
The Best New Restaurants in Washington, Chosen by Top Chefs
In Minneapolis Election, the Future of Policing Is at Stake
The Fremont, California-based firm’s shares jumped as much as 930% in premarket trading and the stock was up 254% at 10:17 a.m. in New York. More than 50 million shares had been traded in the stock by that time, compared to its 12-month daily average of around 660,000.
At the end of trading on Friday, the stock had a market capitalization of $68.1 million. That now stands at around $242 million.
The company has filed for $50 million mixed securities shelf on Friday. It announced restructuring of a joint venture last month and filed for patent applications for some medicines treating depression and attention-deficit hyperactivity disorder in September.
(Updates share move, adds trading volumes in second paragraph.)
Most Read from Bloomberg Businessweek
The Slip-and-Fall King Wants to Save You From Your Next Wipeout
Australia Braces for Life After Covid Zero
Big Teacher Is Watching: How AI Spyware Took Over Schools
Workers Press for Power in Rare Advance for U.S. Labor Movement
You Could Be Competing With Bots to Buy Gifts This Christmas
©2021 Bloomberg L.P.
